The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)

• Eagle Pharmaceuticals announced it will be delaying the release of third-quarter results to review potential adjustments relating to the reporting of sales of PEMFEXY prior to filling its Form 10-Q. The company’s stock has a 52-week low of $8.32 .
• RSI Value: 21.46
• EGRX Price Action: Shares of Eagle Pharmaceuticals fell 2.2% to close at $8.64 on Thursday.

Acutus Medical, Inc. (NASDAQ:AFIB)

• Acutus Medical reported third-quarter financial results and announced strategic realignment of resources and corporate restructuring by approximately 65%. It has a 52-week low of $0.16.
• RSI Value: 24.39
• AFIB Price Action: Shares of Acutus Medical fell 11% to close at $0.1851 on Thursday.

Becton, Dickinson and Company (NYSE:BDX)

Ventyx Biosciences, Inc. (NASDAQ:VTYX)

Read More: Jim Cramer Says 'This Is Not The Time To Sell' This Online Gaming Platform Stock